DIA/MEB Excellence in PV, 8-11 Oct 2024, Amsterdam, NL
|
This DIA/MEB face-to-face training course is designed to provide a strong foundation in all key aspects of European Post-Marketing Safety regulatory requirements.
Description
Organized and delivered in collaboration with the Dutch Medicines Evaluation Board (MEB), this face-to-face interactive training course covers the major pharmacovigilance processes as outlined in GVP I to XVI at intermediate level.
Other than lectures and exercises it gives a lot of room for interaction with the trainers and each other to ensure all your questions are answered. It is designed to strengthen your foundation in all key aspects of European Post-Marketing Safety regulatory requirements for marketed products as well as marketed products in clinical trials.
Furthermore, it includes highlights and updates on the pharmacovigilance legislation as well as the latest news on the ICH activities in pharmacovigilance.
Other than lectures and exercises it gives a lot of room for interaction with the trainers and each other to ensure all your questions are answered. It is designed to strengthen your foundation in all key aspects of European Post-Marketing Safety regulatory requirements for marketed products as well as marketed products in clinical trials.
Furthermore, it includes highlights and updates on the pharmacovigilance legislation as well as the latest news on the ICH activities in pharmacovigilance.